$TKMR Arbutus Biopharma Corp Insider Trading
Get free email notifications about insider trading in Arbutus Biopharma Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arbutus Biopharma Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Arbutus Biopharma Corp for free.
CIK Number: 0001447028
IRS Number: 980597776
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TKMR
Company Address: 100-8900 GLENLYON PARKWAY BURNABY V5J 5J8
Phone number: 604-419-3200
Former name: TEKMIRA PHARMACEUTICALS CORP, date of change: 2008-10-03
Former name: 0736983 B.C. Ltd.
Market Capitalization: $138.47M
Prev close: $2.55
Average Daily Volume: 341,650
Days Low: $2.50
Year Low: $2.35
Year High: $5.48
Arbutus Biopharma Corp Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 4.33 | 250,000 | 1,082,500 | 250,000 | |
Feb 17 2021 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 4.33 | 250,000 | 1,082,500 | 250,000 | |
Feb 17 2021 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Chief Compliance Of ... | Option Exercise | A | 4.33 | 200,000 | 866,000 | 200,000 | |
Feb 17 2021 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 4.33 | 290,000 | 1,255,700 | 290,000 | |
Feb 17 2021 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 4.33 | 290,000 | 1,255,700 | 290,000 | |
Feb 10 2021 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 20,000 | 100,000 | 1,307,457 | 1.3 M to 1.3 M (-1.51 %) |
Dec 16 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 10,000 | 50,032 | 1,327,457 | 1.3 M to 1.3 M (-0.75 %) |
Dec 16 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 30,000 | 150,000 | 1,337,457 | 1.4 M to 1.3 M (-2.19 %) |
Sep 25 2020 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 3.35 | 50,000 | 167,500 | 50,000 | |
Sep 25 2020 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 3.35 | 70,000 | 234,500 | 70,000 | |
Jul 27 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.01 | 20,000 | 100,200 | 1,367,457 | 1.4 M to 1.4 M (-1.44 %) |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 3.35 | 262,313 | 878,749 | 262,313 | |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 |